Virtu KCG Holdings’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Virtu KCG Holdings’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$30K	Sell	36 -92	-72%	-$67.3K	﹤0.01%	2682
2017 Q1	$90K	Buy	128 +94	+276%	+$66.3K	﹤0.01%	2713
2016 Q4	$24K	Sell	34 -8	-19%	-$6.5K	﹤0.01%	3217
2016 Q3	$40K	Buy	+42	New	+$53K	﹤0.01%	2826
2016 Q1	–	Sell	-4	Closed	-$5K	–	3829
2015 Q4	$5K	Buy	+4	New	+$5.22K	﹤0.01%	3407
2015 Q2	–	Sell	-10	Closed	-$29K	–	3866
2015 Q1	$29K	Sell	10 -6	-38%	-$19.2K	﹤0.01%	2907
2014 Q4	$52K	Buy	16 +4	+33%	+$14.2K	﹤0.01%	3419
2014 Q3	$42K	Buy	12 +9	+300%	+$35K	﹤0.01%	3380
2014 Q2	$12K	Sell	3 -24	-89%	-$90.3K	﹤0.01%	3552
2014 Q1	$111K	Buy	27 +14	+108%	+$62.5K	﹤0.01%	3185
2013 Q4	$47K	Buy	13 +9	+225%	+$34.1K	﹤0.01%	3607
2013 Q3	$16K	Buy	+4	New	+$30K	﹤0.01%	3632

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Virtu KCG Holdings's FRTX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) stake by 72% in Q2 2017, selling an estimated $67.3K and leaving 36 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Virtu KCG Holdings first reported a position in FRTX in Q3 2013 and has held it in 12 quarters since. The position peaked at $111K in Q1 2014. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2017.

Virtu KCG Holdings held 36 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $30K as of Q2 2017.
Virtu KCG Holdings sold 92 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $67.3K.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2682 holding.
Virtu KCG Holdings first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and has held it in 12 quarters since.
Virtu KCG Holdings's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $111K in Q1 2014.
28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.